NovaBridge BiosciencesFRA:0VY +6.36%24 FCF Yield % is -8.34 as of Jul. 04, 2026. GuruFocus rates FRA:0VY with a GF Score™ of 24/100 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,413 Biotechnology companies, NovaBridge Biosciences ranks better than 52.09% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
NovaBridge Biosciences FCF Yield % Related Terms
NovaBridge Biosciences FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:0VY vs HUMA, DTIL, ORMP: FCF Yield % Comparison
For the Biotechnology subindustry, NovaBridge Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NovaBridge Biosciences FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NovaBridge Biosciences's FCF Yield % distribution charts can be found below:
* The bar in red indicates where NovaBridge Biosciences's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NovaBridge Biosciences (FRA:0VY) has a FCF Yield % of -8.34 as of Jul. 04, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on NovaBridge Biosciences and its competitors. According to the industry distribution chart, NovaBridge Biosciences ranks #677 out of 1413 companies in the Biotechnology industry, placing it in the top 47.9%.
Is NovaBridge Biosciences' FCF Yield % too high?
NovaBridge Biosciences' current FCF Yield % is -8.34. Based on the distribution chart, NovaBridge Biosciences ranks #677 out of 1413 companies in the Biotechnology industry, which is above the industry midpoint. Overall, NovaBridge Biosciences has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does NovaBridge Biosciences' FCF Yield % compare to HUMA and DTIL?
According to the Biotechnology industry distribution chart, NovaBridge Biosciences ranks #677 out of 1413 companies for FCF Yield %. This puts NovaBridge Biosciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on NovaBridge Biosciences and its competitors. NovaBridge Biosciences's current FCF Yield % is -8.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NovaBridge Biosciences stock overvalued right now?
Based on GuruFocus' analysis, NovaBridge Biosciences (FRA:0VY) is currently considered Possible Value Trap. The current FCF Yield % is -8.34. NovaBridge Biosciences' overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For NovaBridge Biosciences (FRA:0VY), the current FCF Yield % is -8.34 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
24GF Score
Get the complete analysis for FRA:0VY
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0VY has been successfully added to your 
